Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04DZD
|
|||
| Former ID |
DIB006193
|
|||
| Drug Name |
Bidisomide
|
|||
| Synonyms |
Butanamide; SC-40230
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Heart arrhythmia [ICD-11: BC65; ICD-10: I49, I49.8] | Discontinued in Phase 3 | [1] | |
| Company |
GD Searle & Co
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C22H34ClN3O2
|
|||
| Canonical SMILES |
CC(C)N(CCC(CCN1CCCCC1)(C2=CC=CC=C2Cl)C(=O)N)C(=O)C
|
|||
| InChI |
1S/C22H34ClN3O2/c1-17(2)26(18(3)27)16-12-22(21(24)28,19-9-5-6-10-20(19)23)11-15-25-13-7-4-8-14-25/h5-6,9-10,17H,4,7-8,11-16H2,1-3H3,(H2,24,28)
|
|||
| InChIKey |
GTEPPJFJSNSNIH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 116078-65-0
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:135658
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sodium channel unspecific (NaC) | Target Info | Modulator | [2] |
| KEGG Pathway | Dopaminergic synapse | |||
| Reactome | Interaction between L1 and Ankyrins | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000174) | |||
| REF 2 | Bidisomide (SC-40230), a new antiarrhythmic agent: initial study of tolerability and pharmacokinetics. Clin Pharmacol Ther. 1992 Apr;51(4):371-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.